ATRA vs CL · rev $128.9M vs P/E 34, rev $20.38B
Atara Biotherapeutics Inc (ATRA) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
ATRA currently screens at market cap $87.1M. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the ATRA and CL stock pages for the full models.
Not investment advice.